How has been the historical performance of Guj. Themis Bio.?

Answer:The historical performance of Guj. Themis Bio. shows a fluctuating trend in net sales and profitability over the years.

Breakdown:
From March 2019 to March 2025, Guj. Themis Bio. experienced significant growth in net sales, increasing from 41.05 Cr in March 2019 to 150.80 Cr in March 2025, despite a dip to 148.39 Cr in March 2023 and 169.82 Cr in March 2024. The total operating income followed a similar pattern, peaking at 169.82 Cr in March 2024 before declining to 150.80 Cr in March 2025. Operating profit (PBDIT) also saw an upward trend, reaching 71.27 Cr in March 2025, although it was lower than the previous year's 83.11 Cr. Profit before tax decreased from 79.33 Cr in March 2024 to 65.54 Cr in March 2025, while profit after tax followed suit, dropping from 59.16 Cr to 48.77 Cr in the same period. The company's total assets grew from 32.76 Cr in March 2019 to 221.11 Cr in March 2024, reflecting a strong asset base, but the total liabilities also increased, leading to a total liabilities figure of 221.11 Cr in March 2024. Cash flow from operating activities improved to 64.00 Cr in March 2024, indicating better operational efficiency, while cash flow from investing activities was negative at -55.00 Cr, suggesting significant investments. Overall, the financial metrics indicate a company that has expanded its operations and asset base but faced challenges in maintaining profitability in recent years.